The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ.
Kakizoe M, Yao M, Tateishi U, Minamimoto R, Ueno D, Namura K, Makiyama K, Hayashi N, Sano F, Kishida T, Kobayashi K, Noguchi S, Ikeda I, Ohgo Y, Taguri M, Morita S, Inoue T, Kubota Y, Nakaigawa N.
Kakizoe M, et al. Among authors: inoue t.
BMC Cancer. 2014 Jun 2;14:390. doi: 10.1186/1471-2407-14-390.
BMC Cancer. 2014.
PMID: 24885730
Free PMC article.